advertisement

Oculus

11.3.4 Betablocker (817)

Showing records 1 to 25

Display only abstracts from IGR 21-1 in classification 11.3.4 Betablocker

Search within classification 11.3.4 Betablocker

84658 Complete atrioventricular block due to timolol eye drops: a case report and literature review
Wang Z
BMC pharmacology & toxicology 2019; 20: 73 (IGR: 21-1)


85208 Dose- and Time-Dependent Cytotoxicity of Carteolol in Corneal Endothelial Cells and the Underlying Mechanisms
Su W; Zhao J
Frontiers in pharmacology 2020; 11: 202 (IGR: 21-1)


84658 Complete atrioventricular block due to timolol eye drops: a case report and literature review
Denys I
BMC pharmacology & toxicology 2019; 20: 73 (IGR: 21-1)


85208 Dose- and Time-Dependent Cytotoxicity of Carteolol in Corneal Endothelial Cells and the Underlying Mechanisms
Fan TJ
Frontiers in pharmacology 2020; 11: 202 (IGR: 21-1)


84658 Complete atrioventricular block due to timolol eye drops: a case report and literature review
Chen F; Cai L; Wang X; Kapusta DR; Lv Y; Gao J
BMC pharmacology & toxicology 2019; 20: 73 (IGR: 21-1)


82361 Psoriasis precipitated by timolol eye drops. A series of eight cases
Mir-Bonafé JF
Australasian Journal of Dermatology 2020; 61: e91-e93 (IGR: 20-4)


82654 Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Hohberger B
Frontiers in immunology 2019; 10: 2112 (IGR: 20-4)


82317 Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol
Cimolai N
Clinical medicine & research 2019; 17: 90-96 (IGR: 20-4)


82426 New technique to reduce systemic side effects of timolol eye drops: The tissue press method-Cross-over clinical trial
Müller L
Clinical and Experimental Ophthalmology 2020; 48: 24-30 (IGR: 20-4)


82654 Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Kunze R
Frontiers in immunology 2019; 10: 2112 (IGR: 20-4)


82426 New technique to reduce systemic side effects of timolol eye drops: The tissue press method-Cross-over clinical trial
Jensen BP
Clinical and Experimental Ophthalmology 2020; 48: 24-30 (IGR: 20-4)


82361 Psoriasis precipitated by timolol eye drops. A series of eight cases
Rozas-Muñoz E
Australasian Journal of Dermatology 2020; 61: e91-e93 (IGR: 20-4)


82426 New technique to reduce systemic side effects of timolol eye drops: The tissue press method-Cross-over clinical trial
Bachmann LM
Clinical and Experimental Ophthalmology 2020; 48: 24-30 (IGR: 20-4)


82361 Psoriasis precipitated by timolol eye drops. A series of eight cases
Pedemonte-Sarrias E
Australasian Journal of Dermatology 2020; 61: e91-e93 (IGR: 20-4)


82654 Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Wallukat G; Kara K
Frontiers in immunology 2019; 10: 2112 (IGR: 20-4)


82361 Psoriasis precipitated by timolol eye drops. A series of eight cases
Mir-Bonafé M
Australasian Journal of Dermatology 2020; 61: e91-e93 (IGR: 20-4)


82426 New technique to reduce systemic side effects of timolol eye drops: The tissue press method-Cross-over clinical trial
Wong D; Wells AP
Clinical and Experimental Ophthalmology 2020; 48: 24-30 (IGR: 20-4)


82361 Psoriasis precipitated by timolol eye drops. A series of eight cases
Mir-Bonafé JM
Australasian Journal of Dermatology 2020; 61: e91-e93 (IGR: 20-4)


82654 Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Mardin CY; Lämmer R
Frontiers in immunology 2019; 10: 2112 (IGR: 20-4)


82361 Psoriasis precipitated by timolol eye drops. A series of eight cases
Piquero-Casals J
Australasian Journal of Dermatology 2020; 61: e91-e93 (IGR: 20-4)


82654 Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Schlötzer-Schrehardt U
Frontiers in immunology 2019; 10: 2112 (IGR: 20-4)


82361 Psoriasis precipitated by timolol eye drops. A series of eight cases
Puig L
Australasian Journal of Dermatology 2020; 61: e91-e93 (IGR: 20-4)


82654 Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Hosari S; Hosari S; Horn F; Munoz L; Herrmann M
Frontiers in immunology 2019; 10: 2112 (IGR: 20-4)


80713 Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma
Hayashi K
American Journal of Ophthalmology 2019; 205: 91-98 (IGR: 20-3)


81452 Postprandial Head-drops: Insight into Systemic Effects of Ocular Timolol Preparation in Elderly
Bin Waqar SH
Cureus 2019; 11: e4780 (IGR: 20-3)



Issue 21-1

Select Issue


advertisement

Oculus